Dr. François Guilhot

Pr Francois Guilhot,
Head of Oncology Hematology and Cell Therapy Department,
CHU La Miletrie, Poitiers, France

Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: The Eutos Score
May  2, 2011, Journal Blood

Predicting response in CML
February 10. 2011, Journal Blood

François Guilhot at EAH (European Hematology Association)                                               VIDEO
"Importance of quiescent cells"
June 2008, Copenhague

European Registry of CML patients in failure after Imatinib therapy
July 28, 2008, Eurepean Leukemia Net

State-of-the-Art Treatment for Patients With Chronic Myeloid Leukemia: An Expert Interview With Professor Francois Guilhot
October 2007, Medscape

Leucémie myéloïde chronique. Un nouveau traitement porteur d'espoir
January 2007, Paris Match

Indications for Imatinib Mesylate Therapy and Clinical Management
March 4, 2004, The  Oncologist